Key points are not available for this paper at this time.
Inflammatory conditions are key mediators in the progression of various diseases. Silymarin, derived from Silybum marianum seeds and fruits, has shown efficacy in treating a range of liver diseases. The expanding corpus of research on silymarin highlights its promising role in preventing and managing inflammatory conditions and autoimmune without adverse effects. This review discusses the absorption, metabolism, and anti-inflammatory mechanisms of silymarin, exploring its impact on the secretion of inflammatory factors, such as nuclear factor kappa B (NF-κB) pathway, mitogen-activated protein kinase (MAPK) pathway, and antioxidant pathway. We delve into its disease-modifying potential for clinical applications, thereby laying a theoretical foundation for further silymarin research and clinical studies.
Zhao et al. (Wed,) studied this question.